Artículos por temáticas

Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease? Part II: Management, prevention and future perspective

Davey DA.

Neurodegener Dis Manag. 2014;4(3):261-70. doi: 10.2217/nmt.14.14.

Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders

Forlenza OV, De-Paula VJ, Diniz BS.

ACS Chem Neurosci. 2014 Jun 18;5(6):443-50. doi: 10.1021/cn5000309. Epub 2014 May 6.

Cholinesterase inhibitors and add-on nutritional supplements in Alzheimer's disease: a systematic review of randomized controlled trials

Rijpma A, Meulenbroek O, Olde Rikkert MG.

Ageing Res Rev. 2014 Jul;16:105-12. doi: 10.1016/j.arr.2014.06.002. Epub 2014 Jun 27.

Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations

Xu J, Kong X, Qiu L, Geng X, Hu Y, Wang Y.

Expert Opin Ther Pat. 2014 Jul;24(7):791-800. doi: 10.1517/13543776.2014.915943. Epub 2014 May 5.

A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia

Haig GM, Pritchett Y, Meier A, Othman AA, Hall C, Gault LM, Lenz RA.

J Alzheimers Dis. 2014;42(3):959-71. doi: 10.3233/JAD-140291.

Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?

Panza F, Solfrizzi V, Imbimbo BP, Logroscino G.

Expert Opin Biol Ther. 2014 Oct;14(10):1465-76. doi: 10.1517/14712598.2014.935332. Epub 2014 Jun 30.

Letter to the Editor/Case report: why should we not tube-feed patients with severe Alzheimer dementia?

van Bruchem-Visser RL, Oudshoorn C, Mattace Raso FU.

Best Pract Res Clin Gastroenterol. 2014 Apr;28(2):255-6. doi: 10.1016/j.bpg.2014.02.009. Epub 2014 Mar 12.

Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease

Kim MH, Kim SH, Yang WM.

Planta Med. 2014 Oct;80(15):1249-58. doi: 10.1055/s-0034-1383038. Epub 2014 Sep 11.

Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases

Hölscher C.

Biochem Soc Trans. 2014 Apr;42(2):593-9. doi: 10.1042/BST20140016.

Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease

Hogan DB.

Can J Psychiatry. 2014 Dec;59(12):618-23. doi: 10.1177/070674371405901202.

The translocator protein as a drug target in Alzheimer's disease

Chua SW, Kassiou M, Ittner LM.

Expert Rev Neurother. 2014 Apr;14(4):439-48. doi: 10.1586/14737175.2014.896201.

[Vitamin D and Alzheimer's disease: from an intriguing idea to a therapeutic option]

Annweiler C.

Biol Aujourdhui. 2014;208(1):89-95. doi: 10.1051/jbio/2014005. Epub 2014 Jun 23.

Regulation of protein conformation by Pin1 offers novel disease mechanisms and therapeutic approaches in Alzheimer's disease

Driver JA, Zhou XZ, Lu KP.

Discov Med. 2014 Feb;17(92):93-9.

Structure and mechanism of action of tau aggregation inhibitors

Cisek K, Cooper GL, Huseby CJ, Kuret J.

Curr Alzheimer Res. 2014;11(10):918-27. doi: 10.2174/1567205011666141107150331.

Cognitive behavioral group intervention for Alzheimer caregivers

Passoni S, Moroni L, Toraldo A, Mazzà MT, Bertolotti G, Vanacore N, Bottini G.

Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):275-82. doi: 10.1097/WAD.0000000000000033.